Psychiatric and medical comorbidities, associated pain, and health care utilization of patients prescribed buprenorphine
Guardat en:
Mark, T.L., ET AL., Psychiatric and medical comorbidities, associated pain, and health care utilization of patients prescribed buprenorphine. Journal of Substance Abuse Treatment, Vol. 44, no. 5 (2013), p. 481-487.
Ref.
191649
Localització:
SIIS R.991 Archivo
Palabras clave:
Buprenorfina, Diagnóstico dual, Dolor, Drogas ilegales, Drogodependencias, Efectos, Enfermedades mentales, Enfermos, Opiáceos, Servicios de salud, Tratamiento médico, Utilización de servicios
Buprenorfina, Diagnóstico dual, Dolor, Drogas ilegales, Drogodependencias, Efectos, Enfermedades mentales, Enfermos, Opiáceos, Servicios de salud, Tratamiento médico, Utilización de servicios
Ítems similars: Psychiatric and medical comorbidities, associated pain, and health care utilization of patients prescribed buprenorphine
- Non-buprenorphine opioid utilization among patients using buprenorphine
- Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization
- Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder
- PAIN AND CONTINUED OPIOID USE IN INDIVIDUALS RECEIVING BUPRENORPHINE-NALOXONE FOR OPIOID DETOXIFICATION: SECONDARY ANALYSES FROM THE CLINICAL TRIALS NETWORK
- HEROIN DETOXIFICATION WITH BUPRENORPHINE ON AN INPATIENT PSYCHIATRIC UNIT
- Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review